Medicalgorithmics (FRA:B8E) Forward Dividend Yield %: 0.00% (As of Jul. 02, 2026)


FRA:B8E Medicalgorithmics SA FRA:B8E
72 GF Score
Price €5.94
GF Value €6.00
! 4 Warning Signs
View Full Analysis

What is Medicalgorithmics Forward Dividend Yield %?

Medicalgorithmics FRA:B8E -3.10% 72 Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus rates FRA:B8E with a GF Score™ of 72/100 and a GF Value™ of €6.00. The stock has 4 warning signs investors should review. Among 316 Medical Devices & Instruments companies, Medicalgorithmics ranks worse than 316455.38% on this metric.

As of today (2026-07-02), the Forward Annual Dividend Yield of Medicalgorithmics is 0.00%.

As of today (2026-07-02), the Trailing Annual Dividend Yield of Medicalgorithmics is 0.00%.

FRA:B8E's Forward Dividend Yield % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.09
* Ranked among companies with meaningful Forward Dividend Yield % only.

Medicalgorithmics's Dividends per Share for the three months ended in Mar. 2026 was €0.00.

During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of Medicalgorithmics was 18.90% per year. The lowest was -23.70% per year. And the median was 14.00% per year.

The growth rate is calculated with least square regression.

For more information regarding to dividend, please check our Dividend Page.


Medicalgorithmics  (FRA:B8E) Forward Dividend Yield % Explanation

Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.

Dividends may also qualify a lower tax rate for investors.

In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.

You can find the stocks that owned most by Gurus here. Or you can check out Warren Buffett's highest dividend stocks here.


Medicalgorithmics Forward Dividend Yield % Related Terms


FRA:B8E vs ABT, SYK, MDT: Forward Dividend Yield % Comparison

For the Medical Devices subindustry, Medicalgorithmics's Forward Dividend Yield %, along with its competitors' market caps and Forward Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicalgorithmics Forward Dividend Yield % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medicalgorithmics's Forward Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Medicalgorithmics's Forward Dividend Yield % falls into.


FRA:B8E
72GF Score
Medicalgorithmics SA FRA:B8E
Forward Dividend Yield % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medicalgorithmics Forward Dividend Yield % Calculation

Dividend Yield measures how much a company pays out in dividends each year relative to its share price.

What does a Forward Dividend Yield % of 0.00% mean?
Medicalgorithmics (FRA:B8E) has a Forward Dividend Yield % of 0.00% as of Jul. 02, 2026. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medicalgorithmics and its competitors. According to the industry distribution chart, Medicalgorithmics ranks #999999 out of 316 companies in the Medical Devices & Instruments industry.
Is Medicalgorithmics' Forward Dividend Yield % too high?
Medicalgorithmics' current Forward Dividend Yield % is 0.00%. Based on the distribution chart, Medicalgorithmics ranks #999999 out of 316 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Medicalgorithmics has a GF Score™ of 72/100, reflecting its overall financial health beyond just this single metric.
How does Medicalgorithmics' Forward Dividend Yield % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Medicalgorithmics ranks #999999 out of 316 companies for Forward Dividend Yield %. This places Medicalgorithmics in the lower half of its industry. The industry median Forward Dividend Yield % is 2.09. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Forward Dividend Yield % for a Medical Devices & Instruments company?
The median Forward Dividend Yield % among Medical Devices & Instruments companies is 2.09, based on 316 companies in the industry. Companies in the top quartile (top 25%) have a Forward Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Forward Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Forward Dividend Yield % mean?
A high Forward Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Forward dividend yield is the ratio of company's expected dividends to the share price. View historical data on Medicalgorithmics and its competitors. For the Medical Devices & Instruments industry, the median Forward Dividend Yield % is 2.09 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Medicalgorithmics's current Forward Dividend Yield % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medicalgorithmics stock overvalued right now?
Medicalgorithmics (FRA:B8E) has a current Forward Dividend Yield % of 0.00%. The stock's GF Value™ is €6.00, compared to a current price of €5.94 — trading 1% below its estimated fair value. The current Forward Dividend Yield % is 0.00%. Medicalgorithmics' overall GF Score™ is 72/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Forward Dividend Yield % calculated?
Forward Dividend Yield % is calculated from a company's financial statements. For Medicalgorithmics (FRA:B8E), the current Forward Dividend Yield % is 0.00% as of Jul. 02, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medicalgorithmics (FRA:B8E) Overvalued in 2026?

Based on GuruFocus' analysis, Medicalgorithmics stock appears to be undervalued. The current stock price of €5.94 is trading 1% below its estimated GF Value™ of €6.00.

Key valuation signals for FRA:B8E:

  • Forward Dividend Yield %: 0.00%
  • GF Value™: €6.00 vs. price of €5.94 (1% below fair value)
  • GF Score™: 72/100 with 4 warning signs

No single metric tells the full story. See the FRA:B8E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medicalgorithmics Business Description

Other Exchanges MDG:Poland
Address Al Jerozolimskie 81, 19 Floor, Central Tower Building, Warsaw, POL, 02-001
Medicalgorithmics SA is a medical technology company. It is engaged in the development of Digital Signal Processing (DSP) algorithms development and software and hardware electronics design for medical applications. The company specializes in providing advance technological solutions in the field of cardiac diagnostics, with a particular focus on ECG signal analysis. The group concentrates on the production and development of its flagship product Pocket ECG - a system for remote monitoring of cardiac arrhythmias. The offered solutions include algorithms and diagnostic systems used in remote heart monitoring. The company operates in Poland, the USA, and other, with majority of revenue from the USA.
72GF Score

Get the complete analysis for FRA:B8E

Forward Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.94
Price
€6.00
GF Value